These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19952379)

  • 1. Liquid versus foam sclerotherapy.
    Hamel-Desnos C; Allaert FA
    Phlebology; 2009 Dec; 24(6):240-6. PubMed ID: 19952379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
    Gibson K; Gunderson K
    Surg Clin North Am; 2018 Apr; 98(2):415-429. PubMed ID: 29502781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
    Yamaki T; Nozaki M; Iwasaka S
    Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided foam sclerotherapy: safety and efficacy.
    Morrison N
    Phlebology; 2009 Dec; 24(6):239. PubMed ID: 19952378
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
    Gonzalez-Zeh R; Armisen R; Barahona S
    J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of reticular veins and telangiectases.
    Smith PC
    Phlebology; 2015 Nov; 30(2 Suppl):46-52. PubMed ID: 26556703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
    Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foam sclerotherapy for the treatment of varicose veins.
    Bergan J; Cheng V
    Vascular; 2007; 15(5):269-72. PubMed ID: 17976326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of published reports of foam sclerotherapy: what do we know conclusively?
    Myers KA; Roberts S
    Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
    Baeshko A; Shestak N; Korytko S
    Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
    Kölbel T; Hinchliffe RJ; Lindblad B
    Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polidocanol for endovenous microfoam sclerosant therapy.
    Eckmann DM
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.